Christine Borowski

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Mutya Harsch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Borowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
VYNE Therapeutics Inc. Director Stock Option (right to buy) 20,000 12 Dec 2024 Direct

Insider Reports Filed by Christine Borowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYNE VYNE Therapeutics Inc. 12 Dec 2024 1 $0 4 Director 13 Dec 2024, 16:15
VYNE VYNE Therapeutics Inc. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 17:07
VYNE VYNE Therapeutics Inc. 29 Dec 2023 0 $0 3 Director 03 Jan 2024, 17:01